Supernus Pharmaceuticals SUPN
$28.61 +$0.26 (+0.92%)
Market closed · Nov 21, 9:10 am ET · Last extended-hours $28.00 -2.13%
Open$28.39
Prev close$28.35
Day range$28.15 – $29.51
Volume2.83M
Market cap$5.94B
P/E (TTM)–
Dividend yield–
Fundamentals
Latest reported quarter: Q3, ended Sep 2026
Revenue$226.77M+18.0% YoY
Operating profit$22.72M+137.7% YoY
Net profit$20.91M+146.4% YoY
Diluted EPS$0.35+143.8% YoY
Free cash flow$6.38M+110.3% YoY
Operating cash flow$6.61M
Revenue, last 8 quarters
Net profit, last 8 quarters
Diluted EPS by quarter
Free cash flow by quarter
Annual revenue
Profitability & balance sheet
Gross margin87.6%
Operating margin3.2%
Net margin-5.1%
Return on equity-4.2%
Return on assets-3.1%
Return on invested capital-4.3%
Current ratio2.49
Liabilities / assets24.0%
Cash & investments$359.46M
Total debt$28.58M
Net cash (debt)$330.88M
Free cash flow / sales10.1%
Income statement
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Revenue as Reported | $226.77M | $219.06M | $207.71M | $718.95M | $211.57M |
| Total Operating Revenue | $226.77M | $219.06M | $207.71M | $718.95M | $211.57M |
| Cost of Revenue | $27.02M | $33.67M | $23.39M | $74.56M | $23.01M |
| Gross Profit | $199.75M | $185.39M | $184.31M | $644.39M | $188.57M |
| Operating Expense | $177.03M | $188.43M | $190.26M | $681.25M | $174.74M |
| Selling and Admin Expenses | $128.06M | $133.64M | $125.17M | $485.56M | $122.39M |
| -Selling & Marketing Expense | $90.51M | $92.79M | $86.98M | $288.65M | $83.19M |
| -General & Admin Expense | $37.54M | $40.85M | $38.20M | $196.91M | $39.21M |
| Research & Development | $25.76M | $29.46M | $39.44M | $106.24M | $27.83M |
| Depreciation & Amortization & Depletion | $23.22M | $25.33M | $25.64M | $89.46M | $24.53M |
| -Depreciation & Amortization | $23.22M | $25.33M | $25.64M | $89.46M | $24.53M |
| Operating Profit | $22.72M | -$3.04M | -$5.94M | -$36.86M | $13.82M |
| Net Non-Operating Interest Income (Expense) | $1.53M | $315,000.00 | $2.38M | $13.25M | $2.02M |
| Non-Operating Interest Income | $2.25M | $2.63M | $2.38M | $13.25M | $2.02M |
| Non-Operating Interest Expense | $718,000.00 | $2.32M | – | $0.00 | $0.00 |
| Other Income (Expense) | -$1.54M | -$54.92M | -$2.39M | -$25.42M | -$17.76M |
| Special Income (Charges) | -$1.54M | -$54.92M | -$2.39M | -$25.42M | -$17.76M |
| -Less:Restructuring and Mergern & Acquisition | $0.00 | $0.00 | $2.39M | $25.42M | $17.76M |
| -Less:Impairment of Capital Assets | $1.54M | $54.92M | – | $0.00 | – |
| Pretax Profit | $22.71M | -$57.65M | -$5.95M | -$49.03M | -$1.91M |
| Tax | $1.80M | $723,000.00 | -$3.66M | -$10.48M | $2.19M |
| Net Profit | $20.91M | -$58.37M | -$2.29M | -$38.55M | -$4.11M |
| Profit from Continuing Operations | $20.91M | -$58.37M | -$2.29M | -$38.55M | -$4.11M |
| Net Income to Parent Company | $20.91M | -$58.37M | -$2.29M | -$38.55M | -$4.11M |
| Net Income to Common Stockholders | $20.91M | -$58.37M | -$2.29M | -$38.55M | -$4.11M |
| Basic EPS | $0.36 | -$1.01 | -$0.04 | -$0.68 | -$0.07 |
| Diluted EPS | $0.35 | -$1.01 | -$0.04 | -$0.68 | -$0.07 |
Balance sheet
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Assets | $1.40B | $1.43B | $1.50B | $1.45B | $1.45B |
| Total Current Assets | $711.22M | $723.50M | $731.58M | $644.18M | $644.18M |
| Cash and Cash Equivalents & Short-Term Investments | $359.46M | $372.07M | $384.24M | $308.67M | $308.67M |
| -Cash and Cash Equivalents | $175.88M | $179.95M | $184.87M | $128.45M | $128.45M |
| -Short Term Investments | $183.58M | $192.11M | $199.37M | $180.22M | $180.22M |
| Receivables | $214.71M | $211.66M | $182.18M | $187.80M | $187.80M |
| -Accounts Receivable | $214.71M | $211.66M | $182.18M | $187.80M | $187.80M |
| Inventory | $87.11M | $83.92M | $87.06M | $82.39M | $82.39M |
| Other Current Assets | $49.93M | $55.85M | $78.09M | $65.33M | $65.33M |
| Total Non-Current Assets | $686.48M | $704.61M | $769.15M | $808.47M | $808.47M |
| Net PPE | $10.02M | $10.20M | $10.04M | $10.53M | $10.53M |
| -Gross PPE | $29.59M | $29.36M | $28.80M | $28.80M | $28.80M |
| -Accumulated Depreciation | -$19.57M | -$19.17M | -$18.75M | -$18.26M | -$18.26M |
| Goodwill and Other Intangible Assets | $565.67M | $588.89M | $670.38M | $694.34M | $694.34M |
| -Goodwill | $119.43M | $119.43M | $120.67M | $124.88M | $124.88M |
| -Other Intangible Assets | $446.24M | $469.46M | $549.71M | $569.46M | $569.46M |
| Non-Current Deferred Assets | $54.32M | $49.06M | $30.82M | $38.35M | $38.35M |
| Other Non-Current Assets | $56.47M | $56.47M | $57.90M | $65.25M | $65.25M |
| Total Liabilities | $335.21M | $396.88M | $423.92M | $390.93M | $390.93M |
| Total Current Liabilities | $285.40M | $347.38M | $373.93M | $338.17M | $338.17M |
| Payables | $8.52M | $5.59M | $10.17M | $2.68M | $2.68M |
| -Accounts Payable | $8.52M | $5.59M | $10.17M | $2.68M | $2.68M |
| Current Accrued Expenses | $230.75M | $266.61M | $245.95M | $226.16M | $226.16M |
| Short-Term Debt and Capital Lease Obligation | $7.62M | $10.74M | $10.64M | $10.61M | $10.61M |
| -Current Capital Lease Obligation | $7.62M | $10.74M | $10.64M | $10.61M | $10.61M |
| Other Current Liabilities | $10.91M | $40.08M | $82.97M | $69.27M | $69.27M |
| Total Non-Current Liabilities | $49.82M | $49.51M | $49.99M | $52.76M | $52.76M |
| Long Term Debt and Capital Lease Obligation | $28.58M | $29.43M | $30.27M | $30.37M | $30.37M |
| -Long Term Capital Lease Obligation | $28.58M | $29.43M | $30.27M | $30.37M | $30.37M |
| Other Non-Current Liabilities | $21.24M | $20.08M | $19.72M | $22.40M | $22.40M |
| Total Equity | $1.06B | $1.03B | $1.08B | $1.06B | $1.06B |
| Stockholders' Equity | $1.06B | $1.03B | $1.08B | $1.06B | $1.06B |
| Capital Stock | $58,000.00 | $58,000.00 | $58,000.00 | $57,000.00 | $57,000.00 |
| -Common Stock | $58,000.00 | $58,000.00 | $58,000.00 | $57,000.00 | $57,000.00 |
| Additional Paid-In Capital | $584.58M | $574.09M | $561.42M | $543.83M | $543.83M |
| Retained Earnings | $478.13M | $457.21M | $515.58M | $517.88M | $517.88M |
| Gains/Losses Not Affecting Retained Earnings | -$280,000.00 | -$138,000.00 | -$255,000.00 | -$44,000.00 | -$44,000.00 |
| Non-Current Deferred Liabilities | – | – | – | $0.00 | $0.00 |
Cash flow
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Operating Cash Flow | $6.61M | -$4.81M | $66.52M | $47.33M | $19.86M |
| Net cash flow from continuing operations | $6.61M | -$4.81M | $66.52M | $47.33M | $19.86M |
| Net Income from Continuing Operations | $20.91M | -$58.37M | -$2.29M | -$38.55M | -$4.11M |
| Depreciation & Depletion & Amortization | $23.63M | $25.75M | $26.13M | $91.56M | $25.02M |
| Deferred Tax | -$5.30M | -$16.95M | $5.92M | $5.21M | $19.00M |
| Other Non-Cash Items | -$3.33M | -$19.72M | $4.93M | $30.38M | $20.02M |
| Change in Working Capital | -$44.61M | -$2.79M | $21.75M | -$75.16M | -$51.36M |
| -Change in Receivables | -$3.06M | -$29.47M | $5.62M | -$22.30M | -$16.42M |
| -Change in Inventory | -$10.53M | -$306,000.00 | -$105,000.00 | -$7.50M | -$4.18M |
| -Change in Prepaid Assets | $6.26M | $21.66M | -$12.43M | -$13.18M | -$6.91M |
| -Change in Payables and Accrued Expense | -$37.28M | $5.33M | $28.67M | -$32.17M | -$23.85M |
| Net cash flow from investing | $7.72M | $7.09M | -$19.22M | $4.11M | -$51.31M |
| Net Cash Flow from Continuing Investing Activities | $7.72M | $7.09M | -$19.22M | $4.11M | -$51.31M |
| Net PPE Purchase and Sale | -$230,000.00 | -$568,000.00 | $0.00 | -$1.34M | -$427,000.00 |
| Net Investment Purchase and Sale | $7.95M | $7.66M | -$19.22M | $298.54M | -$50.88M |
| Financing Cash Flow | -$18.40M | -$7.20M | $9.12M | $9.13M | $8.53M |
| Net Cash Flow from Continuing Financing Activities | -$18.40M | -$7.20M | $9.12M | $9.13M | $8.53M |
| Net Common Stock Issuance | $2.34M | $4.12M | $13.67M | $37.62M | $8.56M |
| Net Other Financing Charges | -$20.73M | -$11.32M | -$4.56M | -$28.49M | -$31,000.00 |
| Ending Cash Balance | $177.33M | $181.40M | $186.32M | $129.90M | $129.90M |
| Net Change in Cash | -$4.07M | -$4.92M | $56.42M | $60.57M | -$22.92M |
| Beginning Cash Balance | $181.40M | $186.32M | $129.90M | $69.33M | $152.82M |
| Free Cash Flow | $6.38M | -$5.38M | $66.52M | $45.99M | $19.43M |
| Gain/Loss from Continuing Operations | – | $0.00 | -$21,000.00 | $439,000.00 | – |
| Net Business Purchase and Sale | – | – | – | -$293.09M | $0.00 |
| Net Issuance Payments Of Debt | – | – | – | $0.00 | – |
No comments yet — be the first to weigh in on SUPN.
Sign in to join the discussion.